1Rosell R,Abad-Esteve A,Moreno I,et al.A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.Cancer,1990,65(8):1 692-1 699.
3Admas DJ,Knick VC.P-glycoproteir mediated resistance to 5'-nor-anhydrovinblasline (Navelbine)[J]. Lnvest New Drugs,1995,13(1):13-21.
4O'Rourke M.Crawford J,Sichiller,et al.Surrvival advantage for patients with stage Ⅳ Nsclc treated with single agent navelbine in a randomised controlled trial[J].Pra Am Soc oncol 1995,12:243 (Abstr,1149)
5Parker sl,Tong T,Boldens.Cance statisti,(SLJ)[J].CA Cancer J.CLin,1996,46(1):5.
6Fellous A,Meininger V.Binet S,et al.Action of navelbine (NVB) or microtubules-role of Tan and MAP proteins.La:pierre Fabre Oncologie eds.Navelbine:update and new trends [M].Isted.France:John libbey Ewrotext 1td,1991.9.
8Kitagaawa I, Akedo H, Shinkai K, et al. Inhibition of tumor cell invasi on and metastasis by ginsenosis Rg3. Ginseng Rev, 1995, 16:16-20.
9Shinkai K, Akedo H, Mukai M, et al. Inhibition of in vitro tumor cell i nvasion by ginsenoside Rg3. Jpn J Cancer Res, 1996,87:357-362.
10Mochizuki M, Yoo YC, Matsuzawa K, et al. Inhibitory effect of tumor met as tasis in micebysaponin, ginsenoside-Rb2, 20(R)-and 20(S)-ginsenoside-Rg3, ofredg inseng. Biol. Pharm, Bull, 1995, 18(9):1197-1202.
